Literature DB >> 25831462

Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 535 Patients.

Gaya Spolverato1, Yuhree Kim1, Aslam Ejaz1, Sorin Alexandrescu2, Hugo Marques3, Luca Aldrighetti4, T Clark Gamblin5, Carlo Pulitano6, Todd W Bauer7, Feng Shen8, Charbel Sandroussi6, George Poultsides9, Shishir K Maithel10, Timothy M Pawlik1.   

Abstract

IMPORTANCE: Whereas conventional actuarial overall survival (OS) estimates rely exclusively on static factors determined around the time of surgery, conditional survival (CS) estimates take into account the years that a patient has already survived.
OBJECTIVE: To define the CS of patients following liver resection for intrahepatic cholangiocarcinoma (ICC). DESIGN, SETTING, AND PARTICIPANTS: Between January 1, 1990, and December 31, 2013, a total of 535 patients who underwent resection of ICC were identified from an international multi-institutional database. In this retrospective international study conducted from January to June 2014, clinicopathological characteristics, operative details, and long-term survival data were analyzed. Conditional survival estimates were calculated as the probability of survival for an additional 3 years. INTERVENTION: Resection of ICC. MAIN OUTCOMES AND MEASURES: Overall survival and CS.
RESULTS: While actuarial OS decreased over time from 39% at 3 years to 16% at 8 years (P = .002), the 3-year CS (CS₃) increased over time among those patients who survived. The CS₃ at 5 years-the probability of surviving to postoperative year 8 after having already survived to postoperative year 5-was 65% compared with 8-year OS of 16% (P = .002). Factors that were associated with worse OS included larger tumor size (hazard ratio [HR], 1.02; 95% CI, 1.00-1.05; P = .05), multifocal disease (HR, 1.49; 95% CI, 1.19-1.86; P = .01), lymph node metastasis (HR, 2.21; 95% CI, 1.67-2.93; P < .01), and vascular invasion (HR, 1.39; 95% CI, 1.10-1.75; P = .006). The calculated CS₃ exceeded the actuarial survival for all high-risk subgroups. For example, patients with lymph node metastasis had an actuarial OS of 11% at 6 years vs a CS₃ of 49% at 3 years (Δ38%). Similarly, patients with vascular invasion had an actuarial OS of 15% at 6 years compared with a CS₃ of 50% at 3 years (Δ35%). CONCLUSIONS AND RELEVANCE: Conditional survival estimates may provide critical quantitative information about the changing probability of survival over time among patients undergoing liver resection for ICC. Therefore, such estimates can be of significant value to patients and health care professionals.

Entities:  

Mesh:

Year:  2015        PMID: 25831462     DOI: 10.1001/jamasurg.2015.0219

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


  32 in total

1.  Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma.

Authors:  Stefan Buettner; Georgios Antonios Margonis; Yuhree Kim; Faiz Gani; Cecilia G Ethun; George A Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Shishir K Maithel; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2016-08-05       Impact factor: 5.344

2.  Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma.

Authors:  Fabio Bagante; Gaya Spolverato; Matthew Weiss; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Oliver Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-08-24       Impact factor: 3.452

3.  Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients.

Authors:  Suguru Yamashita; Eugene Jon Koay; Guillaume Passot; Rachna Shroff; Kanwal P Raghav; Claudius Conrad; Yun Shin Chun; Thomas A Aloia; Randa Tao; Ahmed Kaseb; Milind Javle; Christopher H Crane; Jean-Nicolas Vauthey
Journal:  Cancer       Date:  2016-12-16       Impact factor: 6.860

4.  Prognosis of Young Survivors of Gastric Cancer in China and the U.S.: Determining Long-Term Outcomes Based on Conditional Survival.

Authors:  Qi-Yue Chen; Qing Zhong; Wei Wang; Shi Chen; Ping Li; Jian-Wei Xie; Jia-Bing Wang; Jian-Xian Lin; Jun Lu; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ju-Li Lin; Hua-Long Zheng; Zhi-Yu Liu; Chao-Hui Zheng; Jun-Sheng Peng; Zhi-Wei Zhou; Chang-Ming Huang
Journal:  Oncologist       Date:  2018-11-23

5.  Role of Lymph Node Dissection in Small (≤ 3 cm) Intrahepatic Cholangiocarcinoma.

Authors:  Andrea Ruzzenente; Simone Conci; Luca Viganò; Giorgio Ercolani; Serena Manfreda; Fabio Bagante; Andrea Ciangherotti; Corrado Pedrazzani; Antonio D Pinna; Calogero Iacono; Guido Torzilli; Alfredo Guglielmi
Journal:  J Gastrointest Surg       Date:  2019-02-28       Impact factor: 3.452

6.  Can laparoscopic liver resection provide a favorable option for patients with large or multiple intrahepatic cholangiocarcinomas?

Authors:  Fangqiang Wei; Chen Lu; Liuxin Cai; Hong Yu; Xiao Liang; Xiujun Cai
Journal:  Surg Endosc       Date:  2016-12-28       Impact factor: 4.584

Review 7.  Liver Transplantation for Cholangiocarcinoma: Insights into the Prognosis and the Evolving Indications.

Authors:  Guergana G Panayotova; Flavio Paterno; James V Guarrera; Keri E Lunsford
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

8.  Conditional probability of long-term survival after resection of hilar cholangiocarcinoma.

Authors:  Stefan Buettner; Georgios A Margonis; Yuhree Kim; Faiz Gani; Cecilia G Ethun; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Shishir K Maithel; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2016-04-24       Impact factor: 3.647

9.  Describing Treatment Patterns for Elderly Patients with Intrahepatic Cholangiocarcinoma and Predicting Prognosis by a Validated Model: A Population-Based Study.

Authors:  Hanlong Zhu; Kun Ji; Wei Wu; Si Zhao; Jian Zhou; Chunmei Zhang; Ruiyi Tang; Lin Miao
Journal:  J Cancer       Date:  2021-03-30       Impact factor: 4.207

10.  An integrative microenvironment approach for laryngeal carcinoma: the role of immune/methylation/autophagy signatures on disease clinical prognosis and single-cell genotypes.

Authors:  Xueran Kang; Yisheng Chen; Bin Yi; Xiaojun Yan; Chenyan Jiang; Bin Chen; Lixing Lu; Yuxing Sun; Runjie Shi
Journal:  J Cancer       Date:  2021-05-13       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.